Page last updated: 2024-08-26

sr141716 and mdl 100907

sr141716 has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Andreu, D; Casadó, V; Castanho, MARB; Cavaco, M; Defaus, S; Gallo, M; Gonzalez, A; Maldonado, R; Moreno, E; Neves, V; Ortega-Alvaro, A; Pardo, L; Robledo, P	1
Arvanitis, L; Bauer, D; Meltzer, HY; Rein, W	1

Trials

1 trial(s) available for sr141716 and mdl 100907

Article	Year
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. The American journal of psychiatry, 2004, Volume: 161, Issue:6 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cannabinoids; Double-Blind Method; Drugs, Investigational; Female; Haloperidol; Humans; Male; Middle Aged; Neurotensin; Peptide Fragments; Piperidines; Placebos; Psychotic Disorders; Pyrazoles; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-3; Research Design; Rimonabant; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome	2004

Article

Year

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.

The American journal of psychiatry, 2004, Volume: 161, Issue:6

Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cannabinoids; Double-Blind Method; Drugs, Investigational; Female; Haloperidol; Humans; Male; Middle Aged; Neurotensin; Peptide Fragments; Piperidines; Placebos; Psychotic Disorders; Pyrazoles; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-3; Research Design; Rimonabant; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome

2004

Other Studies

1 other study(ies) available for sr141716 and mdl 100907

Article	Year
Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects. Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10 Topics: Administration, Oral; Amino Acid Sequence; Analgesics; Animals; Behavior, Animal; Binding Sites; Blood-Brain Barrier; Cannabinoids; Cannabis; Dimerization; Mice; Mice, Inbred ICR; Molecular Dynamics Simulation; Pain; Peptides; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A	2021

Article

Year

Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects.

Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10

Topics: Administration, Oral; Amino Acid Sequence; Analgesics; Animals; Behavior, Animal; Binding Sites; Blood-Brain Barrier; Cannabinoids; Cannabis; Dimerization; Mice; Mice, Inbred ICR; Molecular Dynamics Simulation; Pain; Peptides; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A

2021